Dr. Abdo Edward Kabarriti, MD

Dr. Kabarriti practices at NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital in Brooklyn, New York, part of NYC.

Dr. Kabarriti's NPI, 1306138136, was assigned on May 12, 2011. Dr. Kabarriti holds Pennsylvania license MT199348.

Dr. Kabarriti's primary practice is NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital, at 2601 Ocean Parkway, Brooklyn, NY 11235 in Kings County. The practice phone is (718) 616-4834.

Dr. Kabarriti's primary practice is NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital in Brooklyn, New York, part of NYC. Dr. Kabarriti is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Physician Affiliate Group of New York (PAGNY). Dmand AI also links Dr. Kabarriti to 4 more medical groups and 1 home health agency, each named with a free account. Dr. Kabarriti's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kabarriti practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kabarriti's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kabarriti is licensed in Pennsylvania.

CMS data shows 329 Medicare services from Dr. Kabarriti across 11 procedure codes in 2024, for 223 Medicare patients. Medicare paid $28,889 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 223 Medicare patients who saw Dr. Kabarriti in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kabarriti's median patient age at 75, with 26% women.

In 2024, Dr. Kabarriti wrote 508 Medicare Part D claims for 191 patients. 89% of them were for generic drugs. CMS names the drug for 428 of them, across 10 drugs with 11 or more claims each, at $32,706 in total drug cost. In 2023, CMS named 495 claims across 11 drugs.

Dr. Kabarriti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kabarriti as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 51 general payments to Dr. Kabarriti from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $6,989.